PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people.
Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 200 employees. The company's products are marketed in Europe, North and South America, and Asia.
July 2020 - Zoetis Acquires Fish Vet Group to Enhance Aquaculture Diagnostic Capabilities
Additional Labs and Environmental Testing Further Complement Pharmaq’s Offering to Fish Producers in Key Aquaculture Markets
Pharmaq, acquired by Zoetis in 2015, is dedicated to supporting sustainable growth in the global aquaculture industry. Beyond fish vaccines and therapeutics, Pharmaq also offers PHARMAQ Fishteq vaccination machines and services, and PHARMAQ Analytiq reference lab and diagnostic services which Fish Vet Group now will be a part of. Pharmaq’s research and production facilities are based in Norway, with global operations in commercial fish farming markets.
Chancay: South America's Shanghai or a Chinese Myth? Peru
Twenty months after its inauguration, the port of Chancay fails to lower costs for Peruvian exporters despite cutting travel time to Asia by twelve days.
Foto: Chancay Port / Ocean Alliance
...
Toyosu shows strong segmentation between fresh and frozen tuna Japan
Tokyo wholesale market reports prices up to ¥16,200/kg (US$ 108.00/kg) for domestic fresh tuna, while frozen tuna drops to an average value of ¥3,727/kg (US$ 24.85/kg) despite higher volumes.
...
PHARMAQ AS - Headquarters
Personal Profile
Branches:
Main Company:
Subsidiaries:
Shareholder/Associate at:
Print
